Accuracy of pelvic examination in the assessment of patients with operable cervical cancer

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 4, 2004, Pages 986-992

  Hoffman, Mitchel S ^a,b   Cardosi, Richard J ^a   Roberts, William S ^a   Fiorica, James V ^a   Grendys Jr , Edward C ^a   Griffin, David ^a   Underwood Jr , Paul ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Division of Gynecologic Oncology   (United States)

^c NONE

Author keywords

Cervical cancer; Pelvic examination

Indexed keywords

ADULT; AGED; CONFERENCE PAPER; CORRELATION ANALYSIS; DATA ANALYSIS; ENDOPHYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; PELVIS; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RISK; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; VAGINA;

EID: 2342433258     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.01.019     Document Type: Conference Paper

References (46)

1. M.P Hopkins G.W Morley Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix Cancer 68 1991 272 277
2. F Landoni A Maneo A Colombo F Placa R Milani P Perego Randomized study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer Lancet 350 1997 535 540
3. G.M Thomas A.J Dembo Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer? [Review] Int J Gynecol Cancer 1 1991 1 8
4. R.J Zaino S Ward G Delgado B Bundy H Gore G Fetter Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix Cancer 69 1992 1750 1758
5. R.A.K Samlal J van der Velden F.J.W Ten Kate M.S Schilthuis A.A.M Hart F.B Lammes Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes Cancer 80 1997 1234 1240
6. C.H Lai J.H Hong S Hsueh K.K Ng T.C Chang C.J Tseng Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB and II cervical carcinoma patients with or without pelvic lymph node metastases Cancer 85 1999 1537 1546
7. A Sedlis B.N Bundy M.Z Rotman S.S Lentz L.I Muderspach R.J Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study Gynecol Oncol 73 1999 177 183
8. D.M O'Brien J.A Carmichael Presurgical prognostic factors in carcinoma of the cervix, stages IB and IIA Am J Obstet Gynecol 158 1988 250 254
9. G.M Thomas F.B Stehman Early invasive disease: risk assessment and management Semin Oncol 21 1994 17 24
10. P.W Grigsby Stage IB1 vs IB2 carcinoma of the cervix: should the new FIGO staging system define therapy? [Editorial] Gynecol Oncol 62 1996 135 136
11. A.H Russell Truth and consequences [editorial] Gynecol Oncol 73 1999 175 176
12. W.T Creasman J.T Soper D Clarke-Pearson Radical hysterectomy as therapy for early carcinoma of the cervix Am J Obstet Gynecol 155 1986 964 969
13. G Delgado B Bundy R Zaino B.U Sevin W.T Creasman F Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study Gynecol Oncol 38 1990 352 357
14. B.U Sevin M Nadji B Lampe Y Lu S Hilsenbeck O.R Koechli Prognostic factors of early stage cervical cancer treated by radical hysterectomy Cancer 76 1995 1978 1986
15. L.M Smiley T.W Burke E.G Silva M Morris D.M Gershenson J.T Wharton Prognostic factors in Stage IB squamous cervical cancer patients with low risk for recurrence Obstet Gynecol 77 1991 271 275
16. A.F Fuller Jr. N Elliott C Kosloff W.J Hoskins J.L Lewis Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix Gynecol Oncol 33 1989 34 39
17. R.D Alvarez S.J Soong W.K Kinney G.C Reid M.F Schray K.C Podratz Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early stage squamous carcinoma of the cervix Gynecol Oncol 35 1989 130 135
18. E Burghardt J Baltzer A.H Tulusan J Haas Results of surgical treatment of 1028 cervical cancers studied with volumetry Cancer 70 1992 648 655
19. P Gauthier I Gore H.M Shingleton S.J Soong J.W Orr Jr. K.D Hatch Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix Obstet Gynecol 66 1985 569 574
20. M.A Finan S DeCesare J.V Fiorica R Chambers M.S Hoffman R.C Kline Radical hysterectomy for stage IB1 vs 1B2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol Oncol 62 1996 139 147
21. G.B Kristensen V.M Abeler B Risberg C Tropé M Bryne Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma Gynecol Oncol 74 1999 245 251
22. R.D Alvarez M.E Potter S.J Soong F.L Gay K.D Hatch E.E Partridge Rationale for using pathologic tumor dimensions and nodal status to sub-classify surgically treated stage IB cervical cancer patients Gynecol Oncol 43 1991 108 112
23. P.J Eifel M Morris J.T Wharton M.J Oswald The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 29 1994 9 16
24. T Kamura N Tsukamoto N Tsuruchi T Saito T Matsuyama K Akazawa Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy Cancer 69 1992 181 186
25. G.M Zanetta J.A Katzmann G.L Keeney W.K Kinney S.S Cha K.C Podratz Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma Gynecol Oncol 46 1992 13 19
26. G.L Bremer A.T.M.G Tiebosch H.W.H.M van der Putten J De Haan J.W Arends Basement membranes in cervical cancer: relationship to pelvic lymph node metastasis and prognosis Gynecol Oncol 57 1995 351 355
27. D.L Wiggins C.O Granai M.M Steinhoff P Calabresi Tumor angiogenesis as a prognostic factor in cervical carcinoma Gynecol Oncol 56 1995 353 356
28. I Lombard A Vincent-Salomon P Validire B Zafrani A de la Rochefordiere K Clough Human papillomavirus genotype as a major determinant of the course of cervical cancer J Clin Oncol 16 1998 2613 2619
29. L.D Roman J.C Felix L.I Muderspach T Varkey A.F Burnett D Qian Influence of quantity of lymph-vascular spaceinvasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix Gynecol Oncol 68 1998 220 225
30. K.Y Look V.L Brunetto D.L Clarke-Pearson H.E Averette F.J Major R.D Alvarez An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group Study Gynecol Oncol 63 1996 304 311
31. B.S Bolger M Dabbas A Lopes J.M Monaghan Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma Gynecol Oncol 65 1997 309 313
32. G.C Rodriguez D.L Clarke-Pearson J.T Soper A Berchuck I Synan R.K Dodge The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer Obstet Gynecol 83 1994 445 448
33. H Hricak C.G Lacey L.G Sandles Y.C.F Chang M.L Winkler J.L Stern Invasive cervical carcinoma: comparison of MR imaging and surgical findings Radiology 166 1988 623 631
34. E Burghardt H.M.H Hofmann F Ebner J Haas K Tamussino E Justich Magnetic resonance imaging in cervical cancer: a basis for objective classification Gynecol Oncol 33 1989 61 67
35. H Hricak J.M Quivey Z Campos V Gildengorin T Hindmarsh K.G Bis Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors Int J Radiol Oncol Biol Phys 27 1993 791 801
36. J.M Hawnaur R.J Johnson C.H Buckley V Tindall I Isherwood Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings Clin Radiol 49 1994 443 452
37. S.G Fischetti G Politi E Lomeo G Garozzo S Dileo G Nuciforo Uterine cervical canal carcinoma. Staging and biometric evaluation with magnetic resonance imaging Radiol Med 88 1994 445 452
38. F Ebner K Tamussino H.Y Kressel Magnetic resonance imaging in cervical carcinoma: diagnosis, staging and follow-up Magn Reson Quart 10 1994 22 42
39. L.L Subak H Hricak C.B Powell L Azizi F.L Stern Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging Obstet Gynecol 86 1995 43 50
40. H Hricak C.B Powell K.K Yu E Washington L.L Subak J.L Stern Invasive cervical carcinoma: role of MR imaging in pretreatment work-up–cost minimization and diagnostic efficacy analysis Radiology 198 1996 403 409
41. H Hricak K.K Yu Radiology in invasive cervical cancer AJR Am J Roentgenol 167 1996 1101 1108
42. N.A Mayr V.A Magnotta J.C Ehrhardt J.A Wheeler J.I Sorosky B.C Wen Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix Int J Rad Oncol Biol Phys 35 1996 915 924
43. S Postema L.A.W Peters J Hermans J.B Trimbos P.M.T Pattynama Cervical carcinoma: do fast SE and fat suppression techniques improve MR tumor staging at 0.5 T? J Comput Assist Tomogr 20 1996 807 811
44. F Landoni A Pellegrino G Cormio G Zanetta A Del Maschio A Vanzulli Thinning of preserved stromal cervical ring at magnetic resonance imaging in patients with early cervical cancer: a possible predictor of extra-cervical invasion Int J Gynecol Cancer 6 1996 49 53
45. N.M de Souza G.A.J McIndoe W.P Soutter T Krausz K.M Chui C Hughes Valve of magnetic resonance imaging with an endovaginal receiver coil in the preoperative assessment of stage 1 and IIa cervical neoplasia BJOG 105 1998 500 507
46. H.C Wagenaar J.B.M.Z Trimbos S Postema A Anastasopoulou R.J van der Geest J.H.C Reiber Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer Gynecol Oncol 82 2001 474 482